| |
|
|
|
|
|
|
|||
|
Blood, Vol. 112, Issue 10, 3965-3973, November 15, 2008
Impact of early dose intensity on cytogenetic and molecular responses in chronic- phase CML patients receiving 600 mg/day of imatinib as initial therapy Files in this Data Supplement:
| |||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||